docetaxel anhydrous has been researched along with Leukemia, Myeloid, Acute in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Itagaki, T; Kimura, Y; Shigematsu, H | 1 |
Arslan, C; Uslu, R | 1 |
Amarillo, I; Fisher, SI; Rashidi, A | 1 |
Chao, TY; Huang, TC | 1 |
4 other study(ies) available for docetaxel anhydrous and Leukemia, Myeloid, Acute
Article | Year |
---|---|
[Two Cases of Therapy-Related Myeloid Neoplasms after Docetaxel with Cyclophosphamide Therapy for Breast Cancer].
Topics: Breast Neoplasms; Cyclophosphamide; Docetaxel; Female; Humans; Leukemia, Myeloid, Acute; Neoplasms, Second Primary | 2022 |
Secondary haematological malignancies in the BCIRG 001 study.
Topics: Cyclophosphamide; Docetaxel; Doxorubicin; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Taxoids | 2013 |
BRCA2-associated therapy-related acute myeloid leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Genes, BRCA2; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Taxoids | 2015 |
Mees lines and Beau lines after chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cytarabine; Daunorubicin; Docetaxel; Female; Humans; Leukemia, Myeloid, Acute; Nail Diseases; Taxoids | 2010 |